Realbotix and Bloom Launch UK Care-Home Pilot for Socially Assistive Humanoids
Onconetix highlighted Realbotix's new partnership with Bloom Procurement Services, launching a UK pilot that puts socially assistive humanoid robots into Northeast England care homes to combat loneliness.
Key Takeaways
Realbotix and Bloom Procurement Services launched a UK pilot on July 7, 2026, deploying socially assistive humanoid robots into Northeast England care homes to combat loneliness and support cognitive health.
The robots offer lifelike facial expressions, eye contact, natural conversation, and personalized interaction for companionship, cognitive stimulation, emotional support, and wellbeing check-ins — designed to supplement, not replace, human caregivers.
The pilot will collect evidence on resident engagement, cognitive indicators, staff feedback, and loneliness scores.
Realbotix is now an accredited supplier on Bloom's marketplace, giving UK central and local government buyers a compliant public-sector procurement route to its technology.
The announcement comes mid-way through Onconetix's (Nasdaq: ONCO) all-stock acquisition of Realbotix LLC, agreed February 12, 2026, with the combined company expected to trade on Nasdaq after closing in the second half of 2026.
Kaan Tınmaz
Nasdaq-listed Onconetix (Nasdaq: ONCO) highlighted a new UK partnership from acquisition target Realbotix and Bloom Procurement Services on July 7, 2026, launching an evidence-based pilot that puts socially assistive humanoid robots into Northeast England elder-care homes to test their impact on loneliness, cognitive health, and wellbeing.
How the pilot works
The pilot will deploy Realbotix's AI-powered humanoid robots — featuring lifelike facial expressions, eye contact, natural conversation, and personalized interaction — into UK care settings for companionship, cognitive stimulation, emotional support, and routine wellbeing check-ins. The program is explicitly designed to supplement, not replace, human caregivers. Evidence collected during the pilot will measure resident engagement, cognitive indicators, staff feedback, and loneliness scores.
A Bloom-accredited procurement route
Realbotix has been accredited as a supplier on Bloom's marketplace, opening a compliant public-sector procurement path for UK government buyers to access Realbotix's technology. Bloom is a UK public-sector procurement specialist connecting central and local government to accredited consultancy, technology, and services providers.
Onconetix–Realbotix takeover context
The pilot lands mid-way through Onconetix's previously announced all-stock acquisition of Realbotix LLC, a subsidiary of Realbotix Corp. (TSX-V: XBOT). Onconetix entered a definitive share-exchange agreement on February 12, 2026 to acquire 100% of Realbotix, with the combined company expected to trade on Nasdaq after closing in the second half of 2026, subject to shareholder and regulatory approvals. The partnership joins a rapidly expanding wave of humanoid deployments beyond industrial floors as socially assistive robotics moves into mainstream elder-care procurement.
Reporting based on coverage from GlobeNewswire, StockTitan, and Realbotix Corp.'s SEC filings.
It is an evidence-based pilot launched July 7, 2026 that places Realbotix's AI-powered humanoid robots into Northeast England elder-care homes to test their impact on loneliness, cognitive health, and wellbeing, measuring resident engagement, cognitive indicators, staff feedback, and loneliness scores.
Will the robots replace human caregivers?
No. The program is explicitly designed to supplement, not replace, human caregivers, with robots handling companionship, cognitive stimulation, emotional support, and routine wellbeing check-ins.
How can UK government buyers procure Realbotix robots?
Realbotix has been accredited as a supplier on Bloom's marketplace, a UK public-sector procurement platform connecting central and local government to accredited providers, creating a compliant procurement path.
How does Onconetix fit into this partnership?
Nasdaq-listed Onconetix (ONCO) is acquiring Realbotix LLC, a subsidiary of Realbotix Corp. (TSX-V: XBOT), via an all-stock deal signed February 12, 2026; the combined company is expected to trade on Nasdaq after closing in the second half of 2026, subject to shareholder and regulatory approvals.
